These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 9673385)

  • 1. Absence of frameshift mutations in the bax gene in renal cell cancer (RCC) and transitional cell cancer (TCC).
    Bilim VN; Kawasaki T; Takahashi K; Tomita Y
    Anticancer Res; 1998; 18(3A):1655-9. PubMed ID: 9673385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered expression of beta-catenin in renal cell cancer and transitional cell cancer with the absence of beta-catenin gene mutations.
    Bilim V; Kawasaki T; Katagiri A; Wakatsuki S; Takahashi K; Tomita Y
    Clin Cancer Res; 2000 Feb; 6(2):460-6. PubMed ID: 10690524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BAX somatic frameshift mutations in endometrioid adenocarcinomas of the endometrium: evidence for a tumor progression role in endometrial carcinomas with microsatellite instability.
    Catasús L; Matias-Guiu X; Machin P; Muñoz J; Prat J
    Lab Invest; 1998 Nov; 78(11):1439-44. PubMed ID: 9840618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frameshift somatic mutations in gastrointestinal cancer of the microsatellite mutator phenotype.
    Yamamoto H; Sawai H; Perucho M
    Cancer Res; 1997 Oct; 57(19):4420-6. PubMed ID: 9331106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microsatellite instability in multifocal urothelial carcinoma and effect on BAX and AXIN2.
    Walsh AM; Bailly GG; Bell DG; Norman RW; Gupta R; Zayed E; Nassar BA
    Can J Urol; 2003 Oct; 10(5):2000-6. PubMed ID: 14633328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BAX frameshift mutations in cell lines derived from human haemopoietic malignancies are associated with resistance to apoptosis and microsatellite instability.
    Brimmell M; Mendiola R; Mangion J; Packham G
    Oncogene; 1998 Apr; 16(14):1803-12. PubMed ID: 9583678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The human T-cell factor-4 gene splicing isoforms, Wnt signal pathway, and apoptosis in renal cell carcinoma.
    Shiina H; Igawa M; Breault J; Ribeiro-Filho L; Pookot D; Urakami S; Terashima M; Deguchi M; Yamanaka M; Shirai M; Kaneuchi M; Kane CJ; Dahiya R
    Clin Cancer Res; 2003 Jun; 9(6):2121-32. PubMed ID: 12796377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Expression of the bcl-2 and bax oncoprotein in TCC and its clinical significances].
    Yang B; Gu F; Wang X
    Zhonghua Wai Ke Za Zhi; 1997 Oct; 35(10):602-4. PubMed ID: 10678049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bilharzial related, organ confined, muscle invasive bladder cancer: prognostic value of apoptosis markers, proliferation markers, p53, E-cadherin, epidermal growth factor receptor and c-erbB-2.
    Haitel A; Posch B; El-Baz M; Mokhtar AA; Susani M; Ghoneim MA; Marberger M
    J Urol; 2001 May; 165(5):1481-7. PubMed ID: 11342901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of genes involved in chemoresistance, proliferation and apoptosis in clinical samples of renal cell carcinoma and correlation with clinical outcome.
    Oudard S; Levalois C; Andrieu JM; Bougaran J; Validire P; Thiounn N; Poupon MF; Fourme E; Chevillard S
    Anticancer Res; 2002; 22(1A):121-8. PubMed ID: 12017273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Apoptosis of renal cell carcinoma and apoptotic related genes bcl-2 and bax].
    Yang B; Gu F; Li H; Kong X; Yu L
    Zhonghua Wai Ke Za Zhi; 1998 Jun; 36(6):373-5. PubMed ID: 11825416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BH3 domain mutation of proapoptotic genes Bad, Bmf and Bcl-G is rare in transitional cell carcinomas of the urinary bladder.
    Soung YH; Lee JW; Park WS; Nam SW; Lee JY; Yoo NJ; Lee SH
    Pathology; 2006 Feb; 38(1):33-4. PubMed ID: 16484005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced ING1b gene expression plays an important role in carcinogenesis of non-small cell lung cancer patients.
    Kameyama K; Huang CL; Liu D; Masuya D; Nakashima T; Sumitomo S; Takami Y; Kinoshita M; Yokomise H
    Clin Cancer Res; 2003 Oct; 9(13):4926-34. PubMed ID: 14581367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frameshift mutations in the bax gene are not involved in development of ovarian endometrioid carcinoma.
    Cao SN; Chang KH; Luthra R; Liu J
    Mod Pathol; 2003 Oct; 16(10):1048-52. PubMed ID: 14559989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The study of p53 gene mutation in human bladder cancer].
    Ding Q; Zhang Y; Sun X
    Zhonghua Wai Ke Za Zhi; 1995 Nov; 33(11):684-6. PubMed ID: 8731915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infrequent mutations of the WT1 gene in primary cancers of the adult urinary tract.
    Kageyama Y; Yamamura Y; Oshima H; Ikawa Y
    Jpn J Clin Oncol; 1995 Oct; 25(5):173-8. PubMed ID: 7474403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic alterations involved in the development of gallbladder carcinomas from Greek patients.
    Saetta A; Lazaris AC; Michalopoulos NV; Davaris PS
    Hepatogastroenterology; 2001; 48(41):1284-8. PubMed ID: 11677947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p53 mutations and p53, Waf-1, Bax and Bcl-2 expression in field cancerization of the head and neck.
    Lavieille JP; Gazzeri S; Riva C; Reyt E; Brambilla C; Brambilla E
    Anticancer Res; 1998; 18(6B):4741-9. PubMed ID: 9891551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sensitivity and specificity of p53 protein detection by immunohistochemistry in patients with urothelial bladder carcinoma.
    Salinas-Sánchez AS; Atienzar-Tobarra M; Lorenzo-Romero JG; Sánchez-Sánchez F; Giménez-Bachs JM; Donate-Moreno MJ; Pastor-Navarro H; Hernández-Millán I; Segura-Martín M; Escribano-Martínez J
    Urol Int; 2007; 79(4):321-7. PubMed ID: 18025850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequent expression of Bcl-2 in renal-cell carcinomas carrying wild-type p53.
    Tomita Y; Bilim V; Kawasaki T; Takahashi K; Okan I; Magnusson KP; Wiman KG
    Int J Cancer; 1996 May; 66(3):322-5. PubMed ID: 8621251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.